Jacqueline E. Shea - Feb 26, 2025 Form 4 Insider Report for INOVIO PHARMACEUTICALS, INC. (INO)

Role
Chief Executive Officer, Director
Signature
/s/ Jacqueline E. Shea
Stock symbol
INO
Transactions as of
Feb 26, 2025
Transactions value $
-$22,930
Form type
4
Date filed
2/28/2025, 06:05 PM
Previous filing
May 16, 2024
Next filing
May 12, 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction INO Common Stock Options Exercise +5.85K +17.39% 39.5K Feb 26, 2025 Direct F1
transaction INO Common Stock Tax liability -$4.94K -2.49K -6.31% $1.98 37K Feb 26, 2025 Direct F2
transaction INO Common Stock Options Exercise +18.6K +50.35% 55.6K Feb 26, 2025 Direct F3
transaction INO Common Stock Tax liability -$18K -9.09K -16.33% $1.98 46.6K Feb 26, 2025 Direct F4

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction INO Restricted Stock Unit Options Exercise $0 -5.85K -100% $0.00 0 Feb 26, 2025 Common Stock 5.85K Direct F1
transaction INO Restricted Stock Unit Options Exercise $0 -18.6K -33.33% $0.00 37.3K Feb 26, 2025 Common Stock 18.6K Direct F3
transaction INO Common Stock Option Award $0 +106K $0.00 106K Feb 27, 2025 Common Stock 106K $1.94 Direct F5
transaction INO Restricted Stock Unit Award $0 +85.2K $0.00 85.2K Feb 27, 2025 Common Stock 85.2K Direct F6
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 17,557 restricted stock units granted on February 26, 2022 was as follows: 5,852 shares vested on February 26, 2023; 5,853 shares vested on February 26, 2024; and 5,852 shares vested on February 26, 2025. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both.
F2 The transaction reported represents the withholding of shares by the issuer to satisfy the reporting person's tax withholding obligations in connection with the vesting and settlement of the restricted stock unit award reported in the immediately preceding row and described in footnote (1) herein.
F3 Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 55,895 restricted stock units granted on February 28, 2024 is as follows: 18,632 shares vested on February 26, 2025; 18,632 shares will vest on February 26, 2026; and 18,631 shares will vest on February 26, 2027. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both.
F4 The transaction reported represents the withholding of shares by the issuer to satisfy the reporting person's tax withholding obligations in connection with the vesting and settlement of the restricted stock unit award reported in the immediately preceding row and described in footnote (3) herein.
F5 The vesting schedule for the 105,649 options is as follows: 52,825 shares vested on February 27, 2025 and 52,824 shares will vest on February 26, 2026.
F6 Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 85,201 restricted stock units granted on February 27, 2025 is as follows: 28,401 shares will vest on February 26, 2026; 28,400 shares will vest on February 26, 2027; and 28,400 shares will vest on February 26, 2028. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both.